Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Cikes

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Rheumatology|December 1, 1994
Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseasesJ Markeljević, D Batinić, B Uzarević, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|April 1, 1996
Binding of anti-double stranded (ds) DNA-positive sera to denatured (d) DNA and synthetic poly[dA-dT] x poly[dA-dT] double stranded copolymer in an ELISA formatD Batinić, M Bozićević, A Krstulović, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 30, 1996
Antibodies to Tamm-Horsfall protein in patients treated with extracorporeal shock wave lithotripsy (ESWL)B Jelaković, Z Mareković, I Krhen, et al.
Mayo Clinic Proceedings|May 1, 1988
Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrowN Cikes, M Y Momoi, C L Williams, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1991
T cell subset composition in remission phase of systemic connective tissue diseasesJ Markeljević, M Marusić, B Uzarević, et al.
Lupus|June 20, 2007
Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrualJ Nossent, N Cikes, E Kiss, et al.
Lupus|March 13, 2001
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Rheumatology (Oxford, England)|February 7, 2001
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)A J Swaak, H van de Brink, R J Smeenk, et al.
Rheumatology (Oxford, England)|October 27, 1999
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Rheumatology|December 1, 1994
Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseasesJ Markeljević, D Batinić, B Uzarević, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|April 1, 1996
Binding of anti-double stranded (ds) DNA-positive sera to denatured (d) DNA and synthetic poly[dA-dT] x poly[dA-dT] double stranded copolymer in an ELISA formatD Batinić, M Bozićević, A Krstulović, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 30, 1996
Antibodies to Tamm-Horsfall protein in patients treated with extracorporeal shock wave lithotripsy (ESWL)B Jelaković, Z Mareković, I Krhen, et al.
Mayo Clinic Proceedings|May 1, 1988
Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrowN Cikes, M Y Momoi, C L Williams, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1991
T cell subset composition in remission phase of systemic connective tissue diseasesJ Markeljević, M Marusić, B Uzarević, et al.
Lupus|June 20, 2007
Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrualJ Nossent, N Cikes, E Kiss, et al.
Lupus|March 13, 2001
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Rheumatology (Oxford, England)|February 7, 2001
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)A J Swaak, H van de Brink, R J Smeenk, et al.
Rheumatology (Oxford, England)|October 27, 1999
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.
Pageof 4